S Arlot

The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients

National Incidence and Prevalence of TSH-Secreting Pituitary Adenomas in Sweden

Hepatocellular carcinoma

Amiodarone and the thyroid

Perioperative Management of Patients Undergoing Transsphenoidal Pituitary Surgery

Excess mortality for patients with residual disease following resection of pituitary adenomas

Management of Hepatocellular Carcinoma *

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma

Acromegaly: An Endocrine Society Clinical Practice Guideline

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

Recent advances in hemochromatosis: a 2015 update

Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism

The Diagnosis of Polycystic Ovary Syndrome during Adolescence

Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement

Primary Medical Treatment of Thyrotropin–Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients

2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

The Insulin-Related Ovarian Regulatory System in Health and Disease

Printed educational materials: effects on professional practice and healthcare outcomes

Impact of the introduction of a guideline on the targeted detection of hereditary haemochromatosis.

Efficacy of the Long-Acting Octreotide Formulation (Octreotide-Lar) in Patients with Thyrotropin-Secreting Pituitary Adenomas

A targeted approach significantly increases the identification rate of patients with undiagnosed haemochromatosis

Radioiodine ablation of the thyroid to allow the reintroduction of amiodarone treatment in patients with a prior history of Amiodarone-Induced thyrotoxicosis

Relationship between insulin sensitivity and circulating sex hormone-binding globulin levels in hyperandrogenic obese women.

Myxoedema coma: Response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment

Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias

Evaluation of the Treatment of Thyrotropin-Secreting Pituitary Adenomas with a Slow Release Formulation of the Somatostatin Analog Lanreotide